PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
ANNAPOLIS, Md., July 27 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has signed definitive agreements for the issuance of 2-year, 10% unsecured sen...
Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures
MADISON, N.J., July 15 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) (the "Company") announced today that the Company's offer to purchase Wyeth Floating Rate
Convertible Senior Debentures due 2024 (the "Convertible Debentures") pursuant to the right of holders to surrender their Conve...
LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock
SIOUX FALLS, S.D., June 29 /PRNewswire-FirstCall/ -- LodgeNet Interactive Corporation (Nasdaq: LNET ) today announced that it has successfully completed its offering of 50,000 shares of 10% Series B Cumulative Perpetual
Convertible Preferred Stock, $0.01 par value, with a liquidation preference ...
Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
SEATTLE, June 19 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced the final results of its separate concurrent fixed price exchange offers (each, an "Exchange Offer" and together, the "Exchange Offers") for any and all of the app...
Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
SEATTLE, June 17 /PRNewswire-FirstCall/ --
Holders of Approximately 46.1% of Outstanding Notes Tendered in the Exchange Offers
Outstanding Debt to be Reduced by Approximately $54.8 Million
Future Annual Interest Expense Reduced by Approximately $3.4 Million...
HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
BIRMINGHAM, Ala., June 12 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS ) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A
Convertible Perpetual Preferred Stock, payable on July 15, 2009, to holders of r...
Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
WALTHAM, Mass., May 22 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Serie...
Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes
FRAZER, Pa., May 22 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that the underwriters of its previously announced offering of $435 million in aggregate principal amount of 2.50%
convertible senior subordinated notes due 2014 have exercised in full their over-allotmen...
Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line
Counter top converts to under counter system. Under counter ionizer converts to counter top for travel use.
Carlsbad, CA (PRWEB) May 20, 2009 -- Getting the health benefits of ionized and alkaline mineral water at home or in the office has become a lot easier thanks t...
Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer
SEATTLE, May 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTA: CTIC) today announced that that its Board of Directors has authorized a "Modified Dutch Auction" tender offer (the "Exchange Offer") and that it intends to exchange shares of its common stoc...
Convertible in Medical Technology
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...ff Position No. APB 14-1 (FSP 14-1) for its 2 5/8%
convertible notes, which required Isis to assign a value to its
convertible debt without considering the conversion feature. As a result, Isis is recording its
convertible debt at a discount, which Isis is amortizing over ...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... 5,417
----- -----
Total current liabilities $45,316 $68,374
convertible subordinated
notes 214,955 214,955
Capital lease obligations 19,616 20,347
...
Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease
...es Greenhouse, Innovation Works (Pittsburgh), and several individual investors. The round included both new investments and the conversion of existing
convertible notes.
"This investment facilitates the advancement of our existing lead molecules towards a major milestone," said Cognition Therapeutics P...
Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
...could adversely affect the market for our products or our ability to raise needed financing; actions by our competitors; restrictions contained in our
convertible debt obligations requiring the issuance of shares rather than repayment in cash; and the company's ability to protect its intellectual property. Other...
Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
...dment, Gen-Probe will acquire 4.9 million shares of newly issued DiagnoCure
convertible preferred stock for US$5.0 million (C$6.1 million), representing a premium ...ng the required regulatory approvals from the Toronto Stock Exchange. These
convertible preferred shares are non-voting, and may be exchanged for common shares on ...
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
...GlaxoSmithKline (GSK) -
- $106 million of
convertible debt repurchased for $50 million in cash -
...$106.2 million principal amount of its outstanding
convertible debt at a cost of $50.0 million in cash. The repu...9 million principal amount of the Company's 2 1/4%
convertible Subordinated Notes Due October 2011, and $23.3 mil...
American Dairy Provides Business Update
...nnounces Repurchase of Additional $3.77 Million of
convertible Notes -
BEIJING, Jan. 20 /PRNewswire-FirstCal...
Repurchase of an Additional $3.77 Million of
convertible Notes
The Company also announced that, as part ...Company's outstanding 1% Guaranteed Senior Secured
convertible Notes due 2012 (the "2012 Notes"), the Company com...
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
...e with Nasdaq listing requirements, the impact
of a possible reverse split of the shares of our common stock, the impact
of additional dilution if our
convertible debt is converted to equity; and
whether we will be able to raise sufficient capital in the future, if
required. For a discussion of other factors tha...
SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
...dvancement of this novel compound."
As part of the license agreement, Sunesis has earned a milestone
payment from SARcode of $500,000 and a $375,000
convertible note. The next
payable milestone, if earned, will be for initiation of the Phase 2
clinical program.
About SARcode
SARcode is a privately-held bio...
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
...ing capital $90,722 $107,844
Total assets $96,444 $119,282
4%
convertible subordinated notes due 2011 $18,967 $69,890
Total long-term liabilities ...
Convertible in Medical Products
3.5v Streak Retinoscope Set with Convertible Handle and Soft Case
Description: Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Company:Welch Allyn Medical Products
3.5v Streak Retinoscope Set with Convertible Handle and Hard Case
Description: Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Company:Welch Allyn Medical Products
High Lite Convertible
Description: The
Convertible lets you attach the
High Lite optic directly to your loupes....
Company:BFW, Inc.
z.one Ultrasound Platform
Description:... images, Zone Sonography technology is more than just a revolutionary advancement. The z.one platform, powered by Zone Sonography, is the worlds first
convertible Ultrasound system, instantly converting from a full-featured cart-based system into a premium compact, ultrasound system with all the performance of s...
Company:ZONARE Medical Systems
3.5v Standard Ophthalmoscope Set
Description:... 3.5v Standard Ophthalmoscope Set with
convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Company:Welch Allyn Medical Products
3.5v Coaxial Ophthalmoscope Set
Description:... 3.5v Coaxial Ophthalmoscope Set with
convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Company:Welch Allyn Medical Products
Ophthalmic Diagnostic Set
Features:...desk charger unit, two Lithium-Ion well charging handles delivering twice the on-time at half the weight of conventional NiCad power handles, plus the
convertible handle (runs off NiCad rechargeable or C-cell batteries). ...
Company:Welch Allyn Medical Products
3.5v Ophthalmic Diagnostic Set with AutoStep
Features:...l optical system provides a shadow-free spot and easier entry into undilated pupils.
Its illuminated lens dial clearly identifies settings.
The
convertible handle's smooth, non-abrasive knurled finish ensures a no-slip grip.
The chrome-plated brass handle provides durable, long-life construction. ...
Company:Welch Allyn Medical Products
3.5v Ophthalmic Diagnostic Set
Features:...l optical system provides a shadow-free spot and easier entry into undilated pupils.
Its illuminated lens dial clearly identifies settings.
The
convertible handle's smooth, non-abrasive knurled finish ensures a no-slip grip.
The chrome-plated brass handle provides durable, long-life construction. ...
Company:Welch Allyn Medical Products
Convertible in Biological News
BIO-key to Respond in Court to a Lawsuit Filed by Two Investors
...ny improperly failed to redeem outstanding shares of the Company's Series B
convertible Preferred Stock and Series C
convertible Preferred Stock currently held by the investors in accordance with the term...
Explorations Group Acquires Hawk Biometric Technologies, Inc.
...older value."
Shareholders of Hawk Biometric received a total of 600,000 shares of Explorations' Series B preferred stock, each share of which is
convertible into 100 shares of Explorations' common stock. Explorations is planning a 1-for-6 reverse split of its common stock. The Series B preferred shares wi...
CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services
...ders under Government Wide Acquisition Contracts ("GWACs") and/or schedule contracts with the General Services Administration; and (iv) accounting for
convertible debt instruments; our own ability to achieve the objectives of near term or long range business plans; and other risks described in the company's Secu...
Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
...ly. The increase in the net loss applicable to common
stockholders is due primarily to a non-cash expense for the beneficial
conversion feature of the
convertible preferred shares issued in June 2008
of $371,000. There was no such charge in the comparable period of the prior
year. The basic and diluted loss per ...
Synaptics Reports Record Results for First Quarter of Fiscal 2009
... 7,095 Other accrued liabilities 8,502 9,120 Total current liabilities 53,180 50,509
convertible senior subordinated notes 125,000 125,000 Other liabilities 18,200 17,075
Commitments and conti...
Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
...nded June 30, 2008, compared to $215,000 in the
corresponding prior year period and to a non-cash expense for the
beneficial conversion feature of the
convertible preferred shares issued in
June 2008 of $371,000. There was no such charge in the prior year
comparable period. The basic and diluted loss per share w...
bioMETRX, Inc. Completes Sequiam Asset Purchase
...e issued. The shares issued are restricted securities that are
subject to additional leak-out provisions after the holding period expires.
There is no
convertible debt tied to this transaction. As part of this
transaction, BIL will convert $250,000 of debt into the company's common
stock.
"We are excited to ac...
Communication Intelligence Corporation Closes $3.6 Million Financing
...y with the closing of the Loan, the Company also issued
1,040,000 shares of
convertible Preferred Stock (the "Preferred Shares") in
exchange for the cancellation o...n preference of $1.00 per share over
common stock. The Preferred Shares are
convertible into common stock at the
conversion price of $0.14 per share any time after...
Court Approves Scheme of Arrangement
...he scheme becoming effective, Shire Limited will
be substituted in place of Shire plc as principal obligor under the
U.S.$1,100,000,000 2.75 per cent.
convertible Bonds due 2014 originally
issued by Shire plc (and the terms and conditions of such bonds will be
amended).
Notes to Editors
SHIRE PLC
Shire's s...
BIO-key Reports Third Quarter 2007 Results
... amount in the 2006 period included $5.5 million from
the extinguishment of
convertible debt. The third quarter 2007 net loss per
share was ($0.03) compared to a n... amount in the 2006 period included $7.8 million from
the extinguishment of
convertible debt compared to a similar item of $0.4
million for the nine months ended S...
Convertible in Biological Technology
Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...
PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it has closed on the issuance of 2-year, 10% unsecured ...
Novavax Announces Repayment of $5 Million of Convertible Debt
ROCKVILLE, Md., July 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced that it has repaid the remaining $5.0 million balance of its
convertible notes. These
convertible notes carried a coupon rate of 4.75% payable semi-annually and had a maturity date of July ...
Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of
convertible debt. The company also retired other ...
Verenium Completes Amendment to 8% Senior Convertible Notes
CAMBRIDGE, Mass., July 6 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM ) announced today that the agreement to amend the $29.5 million of outstanding 8% Senior
Convertible Notes due April 1, 2012 (the "Notes") entered into and announced on July 1, 2009 is effective as of 8:00 a....
Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
KENILWORTH, N.J., June 23 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Aug. 31, 2009, to shareholders of record at the close of business on August 7, 2009. ...
Wyeth Announces Holder Right to Surrender Convertible Debentures
MADISON, N.J., June 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) (the "Company") announced today that holders of Wyeth Floating Rate
Convertible Senior Debentures due 2024 (the "Convertible Debentures") have the right to surrender their
Convertible Debentures for purchase by Wyeth pursuant to...
Cell Therapeutics Amends and Restates Its 'Modified Dutch Auction' Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes
SEATTLE, June 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended and restated its "Modified Dutch Auction" tender offer to a fixed price tender offer for any and all of the approximately $118.9 million outstanding...
Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
FRAZER, Pa., May 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today the pricing of its concurrent public offerings of 5 million shares of common stock, at a price of $60 per share, and $435 million in aggregate principal amount of 2.50%
convertible senior subordinated no...
Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
FRAZER, Pa., May 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that it intends to offer, subject to market and other conditions, $300 million of common stock and $350 million in aggregate principal amount of
convertible senior subordinated notes due 2014 through t...